急性心肌梗死患者经皮冠脉介入术后冠状动脉无复流的预防和治疗进展  

Prevention and Treatment of Coronary Artery No-reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

作　　者：潘甜 马康华[1] PAN Tian;MA Kanghua(Department of Cardiology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)

机构地区：[1]重庆医科大学附属第一医院心血管内科

出　　处：《心血管病学进展》2019年第5期730-734,共5页Advances in Cardiovascular Diseases

摘　　要：冠状动脉无复流现象是ST段抬高型心肌梗死经皮冠脉介入术后的一种严重并发症,是发生不良预后的主要预测因子。它可导致梗死部位的不良愈合,不利于左室重构,增加包括充血性心力衰竭、死亡在内的主要不良心血管事件的发生风险。为了实现经皮冠脉介入术冠状动脉靶血管的血流正常,必须提前预见可导致冠状动脉无复流发生的因素,并采取措施预防无复流的发生。现对无复流的预防和治疗进行讨论,并综述有关这种现象管理的最新发现。Coronary artery no-reflow is a serious complication after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and is the main predictor of poor prognosis.It can lead to poor healing of the infarct site,and it is harmful for left ventricular remodeling.Simultaneously,it increases the risk of major adverse cardiovascular events including congestive heart failure and cardiac death.Therefore,in order to achieve normal blood flow in the coronary artery of percutaneous coronary intervention,it is necessary to predict in advance the factors that can cause coronary artery no-reflow,and take measures to prevent the occurrence of no-reflow.The prevention and treatment of no-reflow is now discussed and the latest findings are reviewed.

关 键 词：急性心肌梗死 冠状动脉无复流 经皮冠脉介入术 危险因素 预防 治疗 

分 类 号：R54[医药卫生—心血管疾病]